The financial community news on June 13, according to the CDE official website communication publicity, received the "Class III meeting" applied by Weishi Pharmaceutical (Rugao) Co., Ltd. on June 13, and the current state is "processing."

According to the Measures for the Management of Communication and Exchange of Drug Research and Development and Technical Review (Notice No. 48 of 2020), communication and exchange meetings are divided into Class I, Class II and Class III meetings to communicate and exchange major issues at key stages, and Class III meetings are generally scheduled to be held within 75 days after the application.